Effects of clodronate (dichloromethylene bisphosphonate) on the development of experimental atherosclerosis in rabbits - PubMed (original) (raw)
. 1994 May;123(5):769-76.
Affiliations
- PMID: 8195683
Effects of clodronate (dichloromethylene bisphosphonate) on the development of experimental atherosclerosis in rabbits
R Ylitalo et al. J Lab Clin Med. 1994 May.
Abstract
The effects of clodronate, a bisphosphonate for the treatment of hypercalcemia, on the progress of atherosclerosis were studied in rabbits fed with a high-cholesterol (1%) diet and treated simultaneously with disodium clodronate 0 (saline), 1, 5, or 25 mg/kg intravenously twice a week for 6, 9, and 12 weeks. In 9 to 12 weeks, plasma total cholesterol increased from 0.8 +/- 0.3 mmol/L (mean +/- SD) in rabbits fed the standard diet to 46 +/- 17 mmol/L in animals subjected to high-cholesterol diet. Clodronate did not influence the cholesterol concentration in plasma. None of the parameters studied were changed by clodronate within 6 weeks after beginning the treatment. In 9 to 12 weeks (n = 7 to 9), plasma total Ca++ concentration was decreased from 3.55 +/- 0.12 mmol/L in the saline group to 3.36 +/- 0.16 mmol/L in the group on the greatest clodronate dose (p < 0.05). Free and esterified cholesterol and total Ca++ concentrations in the wall of thoracic aorta were reduced by the greatest dose of clodronate, compared with the groups treated with saline solution or smaller doses of the drug (p < 0.05). At 12 weeks, the greatest dose of clodronate also reduced the visible and lipid-stained atheromatous areas in the thoracic and abdominal aorta, compared with those in the saline and the other clodronate dose groups (p < 0.05). The results suggest that a high dose of clodronate inhibits the development of diet-induced atherosclerosis in rabbits.
Similar articles
- Suppression of immunoreactive macrophages in atheromatous lesions of rabbits by clodronate.
Ylitalo R, Syvälä H, Tuohimaa P, Ylitalo P. Ylitalo R, et al. Pharmacol Toxicol. 2002 Mar;90(3):139-43. doi: 10.1034/j.1600-0773.2002.900305.x. Pharmacol Toxicol. 2002. PMID: 12071335 - Comparison of lycopene and fluvastatin effects on atherosclerosis induced by a high-fat diet in rabbits.
Hu MY, Li YL, Jiang CH, Liu ZQ, Qu SL, Huang YM. Hu MY, et al. Nutrition. 2008 Oct;24(10):1030-8. doi: 10.1016/j.nut.2008.05.006. Epub 2008 Jun 30. Nutrition. 2008. PMID: 18585898 - Combined treatment of probucol with diltiazem regresses atherosclerosis induced by 196 cholesterol diet in rabbit aorta.
Kouzuma R, Tasaki H, Komura T, Nakashima Y, Kuroiwa A, Tanimoto A, Koide O. Kouzuma R, et al. Artery. 1995;21(6):337-51. Artery. 1995. PMID: 8833232 - Effects of atherosclerotic plaque on the enlargement of an experimental model of abdominal aortic aneurysm in rabbits.
Kobayashi H, Matsushita M, Oda K, Nishikimi N, Sakurai T, Komori K. Kobayashi H, et al. Eur J Vasc Endovasc Surg. 2004 Jul;28(1):71-8. doi: 10.1016/j.ejvs.2004.03.015. Eur J Vasc Endovasc Surg. 2004. PMID: 15177235 - Effects of diltiazem on suppression and regression of experimental atherosclerosis.
Sugano M, Nakashima Y, Tasaki H, Takasugi M, Kuroiwa A, Koide O. Sugano M, et al. Br J Exp Pathol. 1988 Aug;69(4):515-23. Br J Exp Pathol. 1988. PMID: 3179199 Free PMC article.
Cited by
- Administration of an LXR agonist promotes atherosclerotic lesion remodelling in murine inflammatory arthritis.
Dragoljevic D, Lee MKS, Pernes G, Morgan PK, Louis C, Shihata W, Huynh K, Kochetkova AA, Bell PW, Mellett NA, Meikle PJ, Lancaster GI, Kraakman MJ, Nagareddy PR, Hanaoka BY, Wicks IP, Murphy AJ. Dragoljevic D, et al. Clin Transl Immunology. 2023 Apr 18;12(4):e1446. doi: 10.1002/cti2.1446. eCollection 2023. Clin Transl Immunology. 2023. PMID: 37091327 Free PMC article. - Platelet in thrombo-inflammation: Unraveling new therapeutic targets.
Sharma S, Tyagi T, Antoniak S. Sharma S, et al. Front Immunol. 2022 Nov 14;13:1039843. doi: 10.3389/fimmu.2022.1039843. eCollection 2022. Front Immunol. 2022. PMID: 36451834 Free PMC article. Review. - Local M-CSF (Macrophage Colony-Stimulating Factor) Expression Regulates Macrophage Proliferation and Apoptosis in Atherosclerosis.
Sinha SK, Miikeda A, Fouladian Z, Mehrabian M, Edillor C, Shih D, Zhou Z, Paul MK, Charugundla S, Davis RC, Rajavashisth TB, Lusis AJ. Sinha SK, et al. Arterioscler Thromb Vasc Biol. 2021 Jan;41(1):220-233. doi: 10.1161/ATVBAHA.120.315255. Epub 2020 Oct 22. Arterioscler Thromb Vasc Biol. 2021. PMID: 33086870 Free PMC article. - The dual role of platelet-innate immune cell interactions in thrombo-inflammation.
Rayes J, Bourne JH, Brill A, Watson SP. Rayes J, et al. Res Pract Thromb Haemost. 2019 Oct 17;4(1):23-35. doi: 10.1002/rth2.12266. eCollection 2020 Jan. Res Pract Thromb Haemost. 2019. PMID: 31989082 Free PMC article. Review. - The role of macrophages in the resolution of inflammation.
Watanabe S, Alexander M, Misharin AV, Budinger GRS. Watanabe S, et al. J Clin Invest. 2019 May 20;129(7):2619-2628. doi: 10.1172/JCI124615. eCollection 2019 May 20. J Clin Invest. 2019. PMID: 31107246 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources